{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:40:43Z","timestamp":1758123643777},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1007\/bf03347809","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T22:57:35Z","timestamp":1397170655000},"page":"253-257","source":"Crossref","is-referenced-by-count":9,"title":["Serum soluble Interleukin-2 receptors as an index of the biological activity of thyroid hormones in hyperthyroidism"],"prefix":"10.1007","volume":"18","author":[{"given":"E.","family":"Koukkou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Thalassinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03347809_CR1","first-page":"646","volume-title":"Endocrinology","author":"K Makenzie","year":"1989","unstructured":"Makenzie K., Zakarijia M. Hyperthyroidism. In: De Groot L.J. (Ed.), Endocrinology. WB Saunders, Philadelphia, 1989, p. 646."},{"key":"BF03347809_CR2","first-page":"722.","volume-title":"Endocrinology","author":"H Studer","year":"1989","unstructured":"Studer H., Gerber H., Peter H.J. Multinodular goiter. In: DeGroot L.J. (Ed.), Endocrinology. WB Saunders, Philadelphia, 1989, p. 722."},{"key":"BF03347809_CR3","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.158.6.1895","volume":"158","author":"DA Cantrell","year":"1983","unstructured":"Cantrell D.A., Smith K.A. Transient expression of IL-2 receptors. Consequences for T cell growth. J. Exp. Med. 158: 1895, 1983.","journal-title":"J. Exp. Med."},{"key":"BF03347809_CR4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","volume":"113","author":"LA Rubin","year":"1990","unstructured":"Rubin L.A., Nelson D.L. The soluble interleukin-2 receptor: biology, function and clinical application. Ann. Intern. Med. 113: 619, 1990.","journal-title":"Ann. Intern. Med."},{"key":"BF03347809_CR5","first-page":"323","volume":"3","author":"CH Pui","year":"1989","unstructured":"Pui C.H. Serum interleukin-2 receptor: clinical and biological implications. Leukaemia 3: 323, 1989.","journal-title":"Leukaemia"},{"key":"BF03347809_CR6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jcem-73-4-771","volume":"73","author":"E Koukkou","year":"1991","unstructured":"Koukkou E., Panayiotidis P., Alevizou-Terzaki V., Thalassinos N. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism. J. Clin. Endocrinol. Metab. 73: 771, 1991.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347809_CR7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF03347915","volume":"14","author":"S Mariotti","year":"1991","unstructured":"Mariotti S., Caturegli P., Barbesino G., Del Prete G.E., Chiovato L., Pinchera A. Circulating soluble interleukin 2 receptor concentrations is increased in both immunogenic and nonim-munogenic hyperthyroidism. J. Endocrinol. Invest. 14: 777, 1991.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03347809_CR8","first-page":"417","volume":"37","author":"S Mariotti","year":"1992","unstructured":"Mariotti S., Caturegli P., Barbesino G., Marino M., Del Prete G.F., Chiovato L., Tonacchera M., De Carli M., Pinchera A. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases. Clin. Endocrinol. (Oxf.) 37: 417, 1992.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347809_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/acta.0.1250253","volume":"125","author":"K Nakanishi","year":"1991","unstructured":"Nakanishi K., Taniguchi Y., Ohta Y. Increased soluble interleukin-2 receptor levels in autoimmune thyroid disease. Acta Endocrinol. (Copenh.) 125: 253, 1991.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03347809_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2265.1974.tb03298.x","volume":"3","author":"DC Anderson","year":"1974","unstructured":"Anderson D.C. Sex hormone binding globulin. Clin. Endocrinol. (Oxf.) 3: 69, 1974.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347809_CR11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2265.1989.tb01245.x","volume":"31","author":"P Caron","year":"1989","unstructured":"Caron P., Bennet A., Barousse C., Nisula B.C., Louvet J.P. Effect of hyperthyroidism on binding proteins for steroid hormones. Clin. Endocrinol. (Oxf.) 31: 219, 1989.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347809_CR12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2265.1992.tb00956.x","volume":"36","author":"HC Ford","year":"1992","unstructured":"Ford H.C., Cooke R.R., Keightley E.A., Feek C.M. Serum levels of free and bound testosterone in hyperthyroidism. Clin. Endocrinol. (Oxf.) 36: 187, 1992.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347809_CR13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jcem-62-6-1309","volume":"62","author":"P Nayer De","year":"1986","unstructured":"De Nayer P., Lambot M.P., Desmons M.C., Rennotte B., Malvaux P., Beckers C. Sex hormone-binding protein in hyperthyroxinemic patients: A discriminator for thyroid status in thyroid hormone resistance and familial dysalbuminemic hyperthyroxinemia. J. Clin. Endocrinol. Metab. 62: 1309, 1986.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347809_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jcem-71-1-19","volume":"71","author":"P Beck-Peccoz","year":"1990","unstructured":"Beck-Peccoz P., Roncoroni R., Mariotti S., Medri G., Marcocci C., Brabant G., Forloni E.., Pinchera A., Faglia G. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): Evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J. Clin. Endocrinol. Metab. 71: 19, 1990.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347809_CR15","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","volume":"735","author":"LA Rubin","year":"1985","unstructured":"Rubin L.A., Kurman C.C., Fritz M.E., Biddison W.E., Boutin B., Yarchoan R., Nelson D.L. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 735: 3172, 1985.","journal-title":"J. Immunol."},{"key":"BF03347809_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2796.1989.tb01391.x","volume":"226","author":"HH Lervang","year":"1989","unstructured":"Lervang H.H., Moller-Petersen J., Ditzel J. Serum beta-2 microglobulin levels in thyroid diseases. J. Intern. Med. 226: 261, 1989.","journal-title":"J. Intern. Med."},{"key":"BF03347809_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jcp.44.1.73","volume":"44","author":"I Roiter","year":"1991","unstructured":"Roiter I., DaRin G., DeMenis E., Foscolo G.C., Legovini P., Conte N. Increased serum beta-2 microglobulin concentrations in hyperthyroid states. J. Clin. Pathol. 44: 73, 1991.","journal-title":"J. Clin. Pathol."},{"key":"BF03347809_CR18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2249.1992.tb06485.x","volume":"88","author":"B Hofmann","year":"1992","unstructured":"Hofmann B., Bass H., Nishanian P., Faisal M., Figlin R.A., Sarna G.P., Fahey J.L. Different lymphoid cell populations produce varied levels of neopterin, beta-2 microglobulin and soluble interleukin-2 receptors when stimulated with IL-2, interferon-gamma or tumor necrosis factor-alpha. Clin. Exp. Immunol. 88: 548, 1992.","journal-title":"Clin. Exp. Immunol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347809.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347809\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T01:32:25Z","timestamp":1689125545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["BF03347809"],"URL":"https:\/\/doi.org\/10.1007\/bf03347809","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}